RxDoctor Payments Data

Steven Ojemann, MD

Neurological Surgery · Aurora, CONPI 1497858294

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 56.5% of the total. Reporting peaked in 2019 at $19,917 and has fallen 83.0% since, to $3,387 in 2025.

$58,711in general payments, 2019–2025

Across 268 payments — averaging $219.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$33K
  • Medtronic$15K
  • Abbott$5K
  • Insightec,inc$3K
  • Stryker$816
  • Johnson & Johnson$529
  • plus $2K from 8 others
$280,811in research payments, 2019–2025

Across 65 payments — averaging $4320.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurocrine Biosciences, Inc.$193K
  • Medtronic$62K
  • Abbott$25K
$189,286in ownership & investment interests, 2019–2025

Across 14 payments — averaging $13,520 each. An ownership or investment interest held by the physician or an immediate family member.

  • Phasor Health, LLC$114K
  • Smarter Devices, LLC$75K

What the payments were for

  • Consulting fees$21,05336%
  • Travel & lodging$23,29940%
  • Food & beverage$14,35924%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,711 in reported general payments places this provider in the 80th percentile of 149 neurological surgery providers in Colorado.

See all neurological surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$92,866
Medicare patients
80
Services billed
122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →